Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Veteran hedge fund consultant still believes in value of alternatives

Tuesday, January 22, 2013

By Beverly Chandler, Opalesque London:

Veteran hedge fund consultant Anthony Hodges is back in the UK and back offering his services to hedge funds and their investors. Hodges has spent some 30 plus years in the industry, having started working as a commodity trading advisor developing what were then revolutionary mechanical trading systems back in 1978. He has most recently spent seven years in Dubai, as the Executive Director in charge of the Ruler’s $1.5bn hedge fund portfolio. In the 1980s and 90s he was Managing Director of Rudolf Wolff Fund Management, a multi-manager hedge fund and subsequently he was at Sabre Fund Management in charge of their fund of funds.

In an interview with Opalesque, Hodges pinpoints technology as providing the biggest developments in the hedge fund industry since he joined it. "Technology has added to liquidity which is good for the markets but also has adverse consequences when things like a flash crash happen, but people learn from that. Hedge fund managers are nimble at figuring out what things work and what don’t work" he says.

Looking back to the hedge fund industry’s early days in the UK, Hodges believes it used to be more of a club, with not many participants. "Now it’s more institutional and widely accepted by the pension fund industry" he says. The managed futures sector, where Hodges started out, is now dominated by the big 20 managed futures funds, which haven’t had a very good three to four years in terms of performance. ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V